In this context, Sun and colleagues utilized liposomes for the simultaneous delivery of MLKL plasmid DNA, zVAD (a pan-caspase inhibitor peptide) and second mitochondria-derived activator of caspase (SMAC) to induce necroptosis in colon cancer cells. Here, MLKL is linked to colonic neoplasm.